Diseases and conditionsKidney diseases and conditionsAutoimmune kidney diseases and conditionsIgA nephropathy
Last updated: November 17, 2026
Medically reviewed by: NKF Education Team
IgA nephropathy (IgAN) is the most common glomerular disease worldwide and remains a leading cause of CKD and kidney failure.
The following programs for healthcare professionals feature experts discussing the impact of IgAN on kidney health, highlighting evidence supporting treatment of the immune-mediated pathogenesis of IgAN, and reviewing the KDIGO 2025 Guideline recommendations for IgAN diagnosis and treatment.
Part 2: From the Gut to the Kidneys: How Biomarkers Are Shaping IgAN Management
Guides for Healthcare Professionals
- Discussing IgA Nephropathy Treatments
- Discussing IgA Nephropathy Diagnosis
- Discussing IgA Nephropathy During the First Nephrology Visit
- Discussion Starting an IgA Nephropathy Treatment
- Discussing Advanced Kidney Disease Planning with Patients Who Have IgA Nephropathy
- Discussing Monitoring a Person Living with IgAN
- IgAN Medication Table
